CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for NLS Pharmaceutics AG is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

NLS Pharmaceutics AG
The Circle 6
Phone: +41 445122150p:+41 445122150 ZUERICH, 8058  Switzerland Ticker: NLSPNLSP
Business Summary
NLS Pharmaceutics AG, formerly NLS 1 Pharma AG, is a Switzerland-based company that operates as a biopharmaceutical company. The Company focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The Company serves customers worldwide.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202312/31/2022YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board RonaldHafner 59 8/1/2015 8/1/2015
Chief Executive Officer, Director AlexanderZwyer 54 8/1/2015 8/1/2015
Chief Scientific Officer EricKonofal 56 7/1/2021 2/1/2021
4 additional Officers and Directors records available in full report.

Business Names
Business Name
NLS Pharmaceutics Inc.
NLSP

General Information
Number of Employees: 2 (As of 5/5/2023)
Outstanding Shares: 39,563,249 (As of 3/22/2024)
Shareholders: 25
Stock Exchange: NASD
Fax Number: +41 445122151


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024